Market Definition
T-cell therapy is a form of immunotherapy that uses engineered T cells to fight cancer by targeting specific antigens on tumor cells. The process involves extracting T cells from a patient’s blood, modifying them with chimeric antigen receptors (CARs), and reinfusing them to destroy cancer cells. Currently, the FDA approves T-cell therapy for treating certain aggressive, relapsed, or refractory non-Hodgkin lymphoma subtypes, such as diffuse large B-cell lymphoma and mantle cell lymphoma.
Get Research Report Sample & TOC: T-cell therapy Market
Market Dynamics
Key Drivers & Trends:
- Cancer Incidence: The growing occurrence of cancer, due to factors like an aging population and lifestyle-related diseases, is a primary driver for T-cell therapy adoption.
- Personalized Medicine: Increased demand for tailored treatments is fueling the growth of this therapy, offering more precise and effective cancer treatments.
- Innovative Therapies: CAR T-cell therapy, where T cells are genetically modified to target cancer cells, is gaining traction, alongside TCR T-cell therapy for solid tumors and other cancers.
- Clinical Development: While promising, T-cell therapies are still under study in clinical trials for broader cancer applications.
Research Objectives
- Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Inquiry before Buying: Request Special Pricing
Market Segments
The T-cell Therapy Market has been segmented into Therapy Type, Indication, Modality, and Region. Based on the Therapy Type, the T-cell Therapy market is segmented into CAR T-cell Therapy, T-cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based. Based on Indication, the market is segmented into Hematologic Malignancies, Solid Tumors, and Others. Based on Modality, the market is bifurcated into Research and Commercialized. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and the Rest of the World.
Key Player
- Amgen (US)
- Bluebird Bio Inc. (US)
- Fate Therapeutics (US)
- Gilead Sciences Inc. (US)
- Merck KGaA (Germany)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Sorrento Therapeutics (US)
- TCR² Therapeutics (US)
- TScan Therapeutics, Inc. (US)
Procure Complete Report (300 Pages PDF with Insights, Charts, Tables, and Figures) @ Buy Now
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porter 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
- Forecast Period – 2024-2033
- Base Year – 2023
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with the lead analyst of the report
- Infographic Excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after-sales service
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest-quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/